IDO1 and rheumatoid arthritis: In summary, we showed that co-infusion of MSCs and Tr1 cells exerts a synergistic immunoregulatory effect through increased IDO expression in MSCs via IFN-β and IL-10 production by Tr1 cells for the alleviation of RA development (Fig. 7).